Back

Long-term TAVI durability - What do we know so far?

1 September 2019 (13:44 - 13:54)
Organised by:
Congress Presentation Part of: Aortic stenosis treatment evolution – Which therapy for which patient? Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Davide Capodanno

University of Catania, Catania (Italy)

5 More presentations in this session

Presentation thumbnail
Session objectives and introduction: the disparity of TAVI adoption across Europe
Professor A. Baumbach (London, GB)
Slides Video
Presentation thumbnail
Multi-modality imaging for diagnosis of aortic stenosis and patient selection for TAVI
Doctor V. Delgado (Barcelona, ES)
Slides Video
Presentation thumbnail
Update on TAVI evidence and latest clinical trials – Quality of life sub analysis
Doctor D. Tchetche (Toulouse, FR)
Slides Video
Presentation thumbnail
The modern heart team approach - Case-based decision making
Professor S. Bleiziffer (Bad Berka, DE) Professor T. Rudolph (Bad Oeynhausen, DE)
Slides Video
Presentation thumbnail
Conclusion and key learnings
Professor F. Maisano (Milan, IT)
Video

Access the full session

Session thumbnail
Aortic stenosis treatment evolution – Which therapy for which patient?

The Event

Event poster

ESC Congress 2019

1 September 2019 13:44 CET
You may be interested in
thumbnail
Congress Presentation
TAVI durability
28 August 2020
thumbnail
Congress Presentation
TAVI Evolut-ion - data, and new devices
26 August 2023
thumbnail
Congress Session
20 years of TAVI: the remaining unmet needs
23 June 2023
thumbnail
Congress Presentation
Echocardiographic assessment of functional changes of prosthetic valve after transcatheter aortic valve implantation in one year follow up: Insights from the multicenter, randomized DIRECT trial.
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources